Reuters logo
6 months ago
BRIEF-Glenmark Pharma gets FDA nod of IND for GSP 304
March 8, 2017 / 3:18 AM / 6 months ago

BRIEF-Glenmark Pharma gets FDA nod of IND for GSP 304

March 8 (Reuters) - Glenmark Pharmaceuticals Ltd:

* Says Glenmark Pharmaceuticals receives FDA clearance of IND for GSP 304

* Says company to initiate phase 2 clinical study in patients with chronic obstructive pulmonary disease Source text: bit.ly/2lCjaQ0 Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below